Stocks
Johnson & Johnson (JNJ) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 368.7% | 390.9% | 383.8% | 352.6% | 332.0% | 947.1% | |||
| Changes by years, y/y, % | +5pp | +22pp | -7pp | -31pp | -21pp | +2.5% | |||
Johnson & Johnson. R&D/CAPEX, %
Johnson & Johnson. R&D/CAPEX, changes, pp
Johnson & Johnson (JNJ) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | LTM ? | |||
| R&D/CAPEX, % | 356.5% | 281.9% | 438.9% | 352.5% | 947.1% | |||
| Changes by years, y/y, % | -21pp | +29pp | -414pp | +25pp | +23pp | |||
| Changes by quarters, q/q, % | +27pp | -75pp | -282pp | -86pp | ||||
